Pharmaceutical composition comprising a selective inhibitor of serotonin reuptake and Galanin (1-15)

摘要

Pharmaceutical composition comprising selective serotonin and galanin (1-15) reuptake inhibitors. The present invention relates to the use of galanin (1-15) or a pharmaceutically acceptable salt thereof for use in combination with a selective serotonin reuptake inhibitor or any other compound that significantly increases the synthesis of postsynaptic 5-HT1A receptors in terminal areas. In particular, the present invention concerns the use of galanin (1-15) or a pharmaceutically acceptable salt thereof useful for increasing and/or providing a faster onset of the therapeutic effect of a selective serotonin reuptake inhibitor or any other compound that significantly increases the synthesis of postsynaptic 5-HT1A receptors in terminal areas.